{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T11:24:35Z","timestamp":1771586675940,"version":"3.50.1"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1,1]]},"DOI":"10.2146\/ajhp110543","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T23:11:57Z","timestamp":1356045117000},"page":"34-42","source":"Crossref","is-referenced-by-count":44,"title":["Diagnosis and treatment of drug-induced hyperthermia"],"prefix":"10.1093","volume":"70","author":[{"given":"Megan E.","family":"Musselman","sequence":"first","affiliation":[{"name":"University of Kansas Hospital, Kansas City, MO; at the time of writing she was Emergency Medicine Specialty Pharmacy Resident, Detroit Receiving Hospital, Detroit, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suprat","family":"Saely","sequence":"additional","affiliation":[{"name":"Postgraduate Year 2 Emergency Medicine Pharmacy Residency Program, Detroit Receiving Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"2019041607545519000_b1-0700034","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/jnnp.46.2.183","article-title":"Cerebellar syndrome following neuroleptic induced heat stroke","volume":"46","author":"Lefkowitz","year":"1983","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2019041607545519000_b2-0700034","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.bpa.2008.06.004","article-title":"Physiology of thermoregulation","volume":"22","author":"Kurz","year":"2008","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"2019041607545519000_b3-0700034","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/bja\/84.5.615","article-title":"Thermoregulation, mild perioperative hypothermia and postanaesthetic shivering","volume":"84","author":"Buggy","year":"2000","journal-title":"Br J Anaesth"},{"key":"2019041607545519000_b4-0700034","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2344\/0003-3006-57.1.25","article-title":"Thermoregulation: physiological and clinical considerations during sedation and general anesthesia","volume":"57","author":"Diaz","year":"2010","journal-title":"Anesth Prog"},{"key":"2019041607545519000_b5-0700034","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00003246-199802000-00046","article-title":"for the Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine in collaboration with the Infectious Disease Society of America. Practice parameters for evaluating new fever in critically ill adult patients","volume":"26","author":"O\u2019Grady","year":"1998","journal-title":"Crit Care Med"},{"key":"2019041607545519000_b6-0700034","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00008480-200404000-00018","article-title":"Management of drug-induced hyperthermia","volume":"16","author":"Halloran","year":"2004","journal-title":"Curr Opin Pediatr"},{"key":"2019041607545519000_b7-0700034","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/mds.23220","article-title":"Neuroleptic malignant syndrome: mechanisms, interactions, and causality","volume":"25","author":"Gillman","year":"2010","journal-title":"Mov Disord"},{"key":"2019041607545519000_b8-0700034","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0736-4679(96)00186-2","article-title":"Prochlorperazine- induced neuroleptic malignant syndrome","volume":"14","author":"Pesola","year":"1996","journal-title":"J Emerg Med"},{"key":"2019041607545519000_b9-0700034","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00007611-199001000-00023","article-title":"Neuroleptic malignant syndrome associated with prochlorperazine","volume":"83","author":"Manser","year":"1990","journal-title":"South Med J"},{"key":"2019041607545519000_b10-0700034","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1345\/aph.1Q325","article-title":"Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome","volume":"45","author":"Musselman","year":"2011","journal-title":"Ann Pharmacother"},{"key":"2019041607545519000_b11-0700034","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1345\/aph.18256","article-title":"Neuroleptic malignant syndrome associated with metoclopramide","volume":"33","author":"Nonino","year":"1999","journal-title":"Ann Pharmacother"},{"key":"2019041607545519000_b12-0700034","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0090-8258(92)90037-J","article-title":"Neuroleptic malignant syndrome associated with metoclopramide antiemetic therapy","volume":"44","author":"Bakri","year":"1992","journal-title":"Gynecol Oncol"},{"key":"2019041607545519000_b13-0700034","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/01.BCR.0000202644.17987.3F","article-title":"Neuroleptic malignant syndrome associated with metoclopramide in a burn patient","volume":"27","author":"Nachreiner","year":"2006","journal-title":"J Burn Care Res"},{"key":"2019041607545519000_b14-0700034","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0006-3223(93)90189-K","article-title":"Neuroleptic malignant syndrome secondary to droperidol","volume":"34","author":"Ratan","year":"1993","journal-title":"Biol Psychiatry"},{"key":"2019041607545519000_b15-0700034","first-page":"101","article-title":"Neuroleptic malignant syndrome induced by droperidol","volume":"7","author":"So PC","year":"2001","journal-title":"Hong Kong Med J"},{"key":"2019041607545519000_b16-0700034","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1440-1614.2005.01568.x","article-title":"Neuroleptic malignant syndrome with promethazine","volume":"39","author":"Mendhekar","year":"2005","journal-title":"Aust N Z J Psychiatry"},{"key":"2019041607545519000_b17-0700034","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/00007611-199910000-00015","article-title":"Neuroleptic malignant syndrome due to promethazine","volume":"92","author":"Chan-Tack","year":"1999","journal-title":"South Med J"},{"key":"2019041607545519000_b18-0700034","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1176\/jnp.7.2.135","article-title":"Neuroleptic malignant syndrome and malignant hyperthermia: end of a controversy?","volume":"7","author":"Keck","year":"1995","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2019041607545519000_b19-0700034","first-page":"151","article-title":"Epidemiology of neuroleptic malignant syndrome","volume":"22","author":"Adityanjee","year":"1999","journal-title":"Clin Neuropharmacol"},{"key":"2019041607545519000_b20-0700034","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1176\/ajp.148.7.880","article-title":"Declining frequency of neuroleptic malignant syndrome in a hospital population","volume":"148","author":"Keck","year":"1991","journal-title":"Am J Psychiatry"},{"key":"2019041607545519000_b21-0700034","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1176\/ajp.142.10.1137","article-title":"Neuroleptic malignant syndrome","volume":"142","author":"Levenson","year":"1985","journal-title":"Am J Psychiatry"},{"key":"2019041607545519000_b22-0700034","first-page":"18","article-title":"Mortality from neuroleptic malignant syndrome","volume":"50","author":"Shalev","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"2019041607545519000_b23-0700034","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/ajp.156.2.169","article-title":"Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome","volume":"156","author":"Gurrera","year":"1999","journal-title":"Am J Psychiatry"},{"key":"2019041607545519000_b24-0700034","volume-title":"Diagnostic and statistical manual of mental disorders","year":"2000","edition":"4th ed."},{"key":"2019041607545519000_b25-0700034","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1176\/ajp.2007.164.6.870","article-title":"Neuroleptic malignant syndrome","volume":"164","author":"Strawn","year":"2007","journal-title":"Am J Psychiatry"},{"key":"2019041607545519000_b26-0700034","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1586\/14737175.7.4.423","article-title":"Neuroleptic malignant syndrome in elderly patients","volume":"7","author":"Caroff","year":"2007","journal-title":"Expert Rev Neurother"},{"key":"2019041607545519000_b27-0700034","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/0006-3223(87)90010-2","article-title":"Neuroleptic malignant syndrome: review and analysis of 115 cases","volume":"22","author":"Addonizio","year":"1987","journal-title":"Biol Psychiatry"},{"key":"2019041607545519000_b28-0700034","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0006-3223(96)00519-7","article-title":"Intravenous injection of levodopa is more effective than dantrolene as therapy for neuroleptic malignant syndrome","volume":"41","author":"Nisijima","year":"1997","journal-title":"Biol Psychiatry"},{"key":"2019041607545519000_b29-0700034","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF01245162","article-title":"Amantadine and the glutamate hypothesis of schizophrenia. Experiences in the treatment of neuroleptic malignant syndrome","volume":"92","author":"Kornhuber","year":"1993","journal-title":"J Neural Transm Gen Sect"},{"key":"2019041607545519000_b30-0700034","first-page":"1001","article-title":"Dantrolene sodium","volume-title":"Goldfrank\u2019s toxicologic emergencies","author":"Sutin","year":"2010","edition":"9th ed."},{"key":"2019041607545519000_b31-0700034","volume-title":"Dantrolene sodium package insert","year":"2008 ."},{"key":"2019041607545519000_b32-0700034","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00000542-198204000-00005","article-title":"Dantrolene in human malignant hyperthermia","volume":"56","author":"Kolb","year":"1982","journal-title":"Anesthesiology"},{"key":"2019041607545519000_b33-0700034","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.1097\/CCM.0b013e3181dda0d4","article-title":"Adverse drug reactions resulting in hyperthermia in the intensive care unit","volume":"38","author":"McAllen","year":"2010","journal-title":"Crit Care Med"},{"key":"2019041607545519000_b34-0700034","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/026988110201600420","article-title":"Possible serotonin syndrome after combination of buspirone and St John\u2019s wort","volume":"16","author":"Dannawi","year":"2002","journal-title":"J Psychopharmacol"},{"key":"2019041607545519000_b35-0700034","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/j.1552-4604.1986.tb02908.x","article-title":"Serotonin syndrome: a case report","volume":"26","author":"Price","year":"1986","journal-title":"J Clin Pharmacol"},{"key":"2019041607545519000_b36-0700034","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1081\/CLT-120037428","article-title":"Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose","volume":"42","author":"Isbister","year":"2004","journal-title":"J Toxicol Clin Toxicol"},{"key":"2019041607545519000_b37-0700034","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"N Engl J Med"},{"key":"2019041607545519000_b38-0700034","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2004-815526","article-title":"Memantine, an NMDA antagonist, prevents the development of hyperthermia in an animal model for serotonin syndrome","volume":"37","author":"Nisijima","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"2019041607545519000_b39-0700034","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0028-3908(94)90071-X","article-title":"Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: microdialysis studies in the awake and anaesthetized rat","volume":"33","author":"Done","year":"1994","journal-title":"Neuropharmacology"},{"key":"2019041607545519000_b40-0700034","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0749-0704(05)70368-7","article-title":"Serotonin syndrome. A clinical update","volume":"13","author":"Mills","year":"1997","journal-title":"Crit Care Clin"},{"key":"2019041607545519000_b41-0700034","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/qjmed\/hcg109","article-title":"The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity","volume":"96","author":"Dunkley","year":"2003","journal-title":"QJM"},{"key":"2019041607545519000_b42-0700034","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1080\/15563650601118101","article-title":"Urinary serotonin level is associated with serotonin syndrome after moclobemide, sertraline, and citalopram overdose","volume":"45","author":"Brvar","year":"2007","journal-title":"Clin Toxicol (Phila)"},{"key":"2019041607545519000_b43-0700034","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1176\/ajp.148.6.705","article-title":"The serotonin syndrome","volume":"148","author":"Sternbach","year":"1991","journal-title":"Am J Psychiatry"},{"key":"2019041607545519000_b44-0700034","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/cc6177","article-title":"Bench-to-bedside review: mechanisms and management of hyperthermia due to toxicity","volume":"11","author":"Eyer","year":"2007","journal-title":"Crit Care"},{"key":"2019041607545519000_b45-0700034","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1176\/ajp.154.6.884a","article-title":"Cyproheptadine: a potent in vivo serotonin antagonist","volume":"154","author":"Kapur","year":"1997","journal-title":"Am J Psychiatry"},{"key":"2019041607545519000_b46-0700034","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/026988119901300111","article-title":"The serotonin syndrome and its treatment","volume":"13","author":"Gillman","year":"1999","journal-title":"J Psychopharmacol"},{"key":"2019041607545519000_b47-0700034","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0749-0704(05)70369-9","article-title":"Drug- induced hyperthermia","volume":"13","author":"Chan","year":"1997","journal-title":"Crit Care Clin"},{"key":"2019041607545519000_b48-0700034","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3109\/15563650.2010.543906","article-title":"2009 annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 27th annual report","volume":"48","author":"Bronstein","year":"2010","journal-title":"Clin Toxicol (Phila)"},{"key":"2019041607545519000_b49-0700034","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1139\/H07-185","article-title":"Children\u2019s thermoregulation during exercise in the heat: a revisit","volume":"33","author":"Falk","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"key":"2019041607545519000_b50-0700034","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00063110-200306000-00018","article-title":"Drug-induced hyperthermia and muscle rigidity: a practical approach","volume":"10","author":"Hadad","year":"2003","journal-title":"Eur J Emerg Med"},{"key":"2019041607545519000_b51-0700034","first-page":"759","article-title":"Physostigmine salicylate: antidote in depth (A12)","volume-title":"Goldfrank\u2019s toxicologic emergencies","author":"Howland","year":"2010","edition":"9th ed."},{"key":"2019041607545519000_b52-0700034","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1017\/S1481803500012598","article-title":"Dantrolene in the treatment of MDMA- related hyperpyrexia: a systematic review","volume":"12","author":"Grunau","year":"2010","journal-title":"CJEM"},{"key":"2019041607545519000_b53-0700034","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0196-0644(85)80934-3","article-title":"Propranolol- induced hypertension in treatment of cocaine intoxication","volume":"14","author":"Ramoska","year":"1985","journal-title":"Ann Emerg Med"},{"key":"2019041607545519000_b54-0700034","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","article-title":"Malignant hyperthermia","volume":"2","author":"Rosenberg","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"2019041607545519000_b55-0700034","first-page":"700","article-title":"Incidence of malignant hyperthermia in Denmark","volume":"64","author":"Ording","year":"1985","journal-title":"Anesth Analg"},{"key":"2019041607545519000_b56-0700034","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00000542-200503000-00007","article-title":"Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the North American population","volume":"102","author":"Sambuughin","year":"2005","journal-title":"Anesthesiology"},{"key":"2019041607545519000_b57-0700034","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00003643-200110000-00002","article-title":"Malignant hyperthermia","volume":"18","author":"Wappler","year":"2001","journal-title":"Eur J Anaesthesiol"},{"key":"2019041607545519000_b58-0700034","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","article-title":"Dantrolene\u2014a review of its pharmacology, therapeutic use and new developments","volume":"59","author":"Krause","year":"2004","journal-title":"Anaesthesia"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/70\/1\/34\/28456285\/ajhp0034.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:19:00Z","timestamp":1687911540000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/70\/1\/34\/5112755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp110543","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,1,1]]},"published":{"date-parts":[[2013,1,1]]}}}